Clinical Trial Update: Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating addition of paracetamol to WHO Step III opioids for chronic cancer pain control has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Paracetamol (acetaminophen)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Pain | Phase 4 | Status: TERMINATED